Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medipharm Labs Corp T.LABS

Alternate Symbol(s):  MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes,... see more

TSX:LABS - Post Discussion

Medipharm Labs Corp > $33.3 Million raised at $0.58 = Buytime at $0.47 :)
View:
Post by 1hot-techwoman on Mar 05, 2021 1:38pm

$33.3 Million raised at $0.58 = Buytime at $0.47 :)

MediPharm Labs Closes Previously Announced Bought Deal Equity Financing

Friday, March 5, 2021, 8:56 AM ET
 

MediPharm Labs Closes Previously Announced Bought Deal Equity Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES

TORONTO, March 05, 2021 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE:MLZ) ("MediPharm Labs" or the "Company") a global leader in specialized, research-driven pharmaceutical-quality cannabis extraction, distillation and derivative products, is pleased to announce the closing of its previously announced "bought deal" offering of units of the Company (the "Units") for total gross proceeds of $33,350,000. The Company sold 57,500,000 Units at a price of $0.58 per Unit,
Comment by mdjbrown on Mar 06, 2021 9:04am
Deep pockets had no problem shelling out a premium of .58 cents while the shareprice has been dropping hard this past couple weeks Once the manipulation to hold this train back stops, it will leave the station all cashed up with lots of news pushing it north bound All aboard!
Comment by 1hot-techwoman on Mar 08, 2021 7:49am
Comment by 1hot-techwoman on Mar 08, 2021 3:20pm
Sell me your shares at $0.46-$0.465 :) :) 
Comment by 1hot-techwoman on Mar 08, 2021 4:06pm
Thanks to whom ever sold to me...lol :) Filled :)
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities